LYTIR

Congress · House of Representatives · PA03

Dwight Evans (D-PA03)

Traded or reported in the 12 months to Nov 19, 2026: 8 sales (at least $22K). Reported a median of 8 days after the trade. 7 stocks and other assets in the reports: 7 trimming.

What their reported trades show

Built only from the trades this member made or reported in the last 12 months. Amounts are the ranges members report; anything reported before then is not seen, and the yearly financial disclosure reports are not included, so this is not a full account of what they own.

Building = only purchases reported · Trimming = only sales reported · Sold out = latest report is a full sale · Mixed = purchases and sales reported. Newest trade first.

Stock or fundWhat the reports showPurchasesreported rangeSalesreported rangeLast trade
INTCIntel Corporation - Common Stock (INTC) [ST]Trimming––2$2K–$30KJun 10, 2026
GDGeneral Dynamics Corporation Common Stock (GD) [Trimming––1$1K–$15KJun 10, 2026
AMTAmerican Tower Corporation (AMT) [ST]Trimming––1$1K–$15KMay 11, 2026
TMOThermo Fisher Scientific Inc Common Stock (TMO) Trimming––1$1K–$15KMay 7, 2026
PWRQuanta Services, Inc. Common Stock (PWR) [ST]Trimming––1$1K–$15KMay 7, 2026
MUMicron Technology, Inc. - Common Stock (MU) [ST]Trimming––1$15K–$50KMar 24, 2026
CVSCVS Health Corporation Common Stock (CVS) [ST]Trimming––1$1K–$15KNov 21, 2025

When they traded

The 7 stocks or funds with the most reported trades, last 12 months. One dot = one reported trade (all the same size: amounts are ranges).

purchase (above the line)sale (below)full sale
DecJanFebMarAprMayJunJulAugSepOctNovINTCAMTCVSGDMUPWRTMOJunJulAugSepOctNovINTCAMTCVSGDMUPWRTMO

On a small screen the strip shows the last 6 months.

Reported in the last 30 days

  • No trades reported between Oct 20, 2026 and Nov 19, 2026.
About this member and these reports

Committees: Committee on Ways and Means Source: House Clerk member data, as of Nov 19, 2026.

Periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report; the trade date is when it happened, and the report can come up to 45 days later. Each row says how many days after the trade it was reported, and says "late" when that was over 45 days. A row marked "amended filing" shows the date of the amendment, not of the first report, so it has no day count and is left out of the median. How to read these

Trades by month
Trades reported, by month made (last 12 months)Purchases: 0 in total; Sales: 7 in total.Mar: Sales 1May: Sales 4Jun: Sales 2DecJanFebMarAprMayJunJulAugSepOctNov
Purchases above the line: 0Sales below: 7
Count of transactions in this member's STOCK Act periodic transaction reports, by the month each trade was made. A report can arrive up to 45 days later.
Every reported trade (8 of 8 shown)
  1. INTCSale: Intel Corporation - Common Stock (INTC) [ST] Jun 10, 2026 reported Jun 24, 2026 14 days later Stocks (including ADRs) $1,001 - $15,000
  2. GDSale: General Dynamics Corporation Common Stock (GD) [ST] Jun 10, 2026 reported Jun 24, 2026 14 days later Stocks (including ADRs) $1,001 - $15,000
  3. AMTSale: American Tower Corporation (AMT) [ST] May 11, 2026 reported May 15, 2026 4 days later Stocks (including ADRs) $1,001 - $15,000
  4. PWRSale: Quanta Services, Inc. Common Stock (PWR) [ST] May 7, 2026 reported May 15, 2026 8 days later Stocks (including ADRs) $1,001 - $15,000
  5. INTCSale: Intel Corporation - Common Stock (INTC) [ST] May 7, 2026 reported May 15, 2026 8 days later Stocks (including ADRs) $1,001 - $15,000
  6. TMOSale: Thermo Fisher Scientific Inc Common Stock (TMO) [ST] May 7, 2026 reported May 15, 2026 8 days later Stocks (including ADRs) $1,001 - $15,000
  7. MUSale: Micron Technology, Inc. - Common Stock (MU) [ST] Mar 24, 2026 reported Apr 20, 2026 27 days later Stocks (including ADRs) $15,001 - $50,000
  8. CVSSale: CVS Health Corporation Common Stock (CVS) [ST] Nov 21, 2025 reported May 15, 2026 amended filing Stocks (including ADRs) $1,001 - $15,000

Source: House Clerk and Senate periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.